Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophr...
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Treatment resistant schizophrenia (TRS), affecting approximately one-third of patients with schizophrenia, is associated with a serious impairment in global psychosocial functioning. Clozapine is the only licensed drug for TRS. However its prescription remains limited by its side effects requiring mandatory monitoring. The need to identify clinical...
Alternative Titles
Full title
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7feafd787a884556b7db28dda7fe9cc6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7feafd787a884556b7db28dda7fe9cc6
Other Identifiers
ISSN
0010-440X
E-ISSN
1532-8384
DOI
10.1016/j.comppsych.2021.152280
